Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
PharmaEngine Announces Positive Topline Results from Global Pivotal Trial of PEP503 (NBTXR3) in Soft Tissue Sarcoma 2018-06-22 08:07
1